| Literature DB >> 33766974 |
Sandeep Pagali1, Riddhi S Parikh2.
Abstract
A 54-year-old woman presented with pruritic rash and hives of 3 days' duration followed by shortness of breath for 1 day. SARS-CoV-2 PCR test for COVID-19 was positive. Cutaneous manifestations of COVID-19 include acral lesions, urticarial rash, erythematous maculopapular rash, vascular rashes and vesicular rash. The cutaneous manifestations are mostly described as self-limiting. Urticarial rashes are not reported as the initial presentation symptom of COVID-19 infection but mostly noted to occur at the same time or after the onset of non-cutaneous symptoms. Management of cutaneous manifestations of COVID-19 affecting quality of life has not been well studied. Antihistamine therapy is the primary recommended therapy. Role of antiviral therapy for severe cases of rash needs to be further assessed. © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: COVID-19; dermatology
Mesh:
Substances:
Year: 2021 PMID: 33766974 DOI: 10.1136/bcr-2021-241793
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X